Sex, Race, and the Quality of Life Factors Most Important to Patients’ Well-Being Among Those Seeking Bariatric Surgery
- 239 Downloads
Evidence suggests obesity-related social stigma and impairment in work function may be the two most detrimental quality of life (QOL) factors to overall well-being among patients seeking weight loss surgery (WLS); whether the relative importance of QOL factors varies across patient sex and race/ethnicity is unclear.
We interviewed 574 patients seeking WLS at two centers. We measured patient’s health utility (preference-based well-being measure) as determined via standard gamble scenarios assessing patients’ willingness to risk death to achieve weight loss or perfect health. Multivariable models assessed associations between patients’ utility and five weight-related QOL domains stratified by gender and race: social stigma, self-esteem, physical function, public distress (weight stigma), and work life.
Depending on patients’ sex and race/ethnicity, mean utilities ranged from 0.85 to 0.91, reflecting an average willingness to assume a 9–15 % risk of death to achieve their most desired health/weight state. After adjustment, African Americans (AAs) reported higher utility than Caucasians (+0.054, p = 0.03), but utilities did not vary significantly by sex. Among Caucasian and AA men, impairment in physical functioning was the most important factor associated with diminished utility; social stigma was also a leading factor for Caucasian men. Among Caucasian women, self-esteem and work function appeared equally important. Social stigma was the leading contributor to utility among AA women; QOL factors did not appear as important among Hispanic patients.
AAs reported higher utilities than Caucasian patients. Individual QOL domains that drive diminished well-being varied across race/ethnicity and sex.
KeywordsRace Quality of life Health utility Bariatric surgery Obesity
The study was funded by a grant from the National Institutes of Health (R01DK073302, PI Wee). Dr. Wee is also supported by a NIH Midcareer Mentorship Award (K24DK087932). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. Ms. Huskey had full access to the data and takes responsibility for the integrity and accuracy of the data.
Compliance with Ethical Standards
The study was funded by a grant from the National Institutes of Health (R01DK073302, PI Wee). Dr. Wee is also supported by a NIH Midcareer Mentorship Award (K24DK087932).
Conflict of Interest
Dr. Apovian reports grants from National Institutes of Health, from Myos, from Aspire Bariatrics, and from GI Dynamics; grants and personal fees from Amylin, from Sanofi-Aventis, from Orexigen, and from Takeda; personal fees from Merck, from Johnson & Johnson, from Arena, from Nutrisystem, from Zafgen, from EnteroMedics, and from NovoNordisk for work unrelated to the current project. All other authors declare they have no conflict of interest.
- 1.Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. National Institutes of Health. Obes Res. 1998;6 Suppl 2:51S-209S.Google Scholar
- 8.The medium and the message of Ebola. Lancet. 2014;384(9955):1641.Google Scholar
- 9.Shepard DS. Cost-effectiveness in health and medicine. By M.R. Gold, J.E. Siegel, L.B. Russell, and M.C. Weinstein (eds). New York: Oxford University Press, 1996. J Ment Health Policy Econ. 1999;2(2):91–2.Google Scholar
- 15.Wee CC, Davis RB, Huskey KW, Jones DB, Hamel MB. Quality of life among obese patients seeking weight loss surgery: the role of obesity-related social stigma and functional status. J Gen Intern Med. 2012.Google Scholar
- 17.Consequences of a competitive research culture. Lancet. 2014;384(9960):2084.Google Scholar